Safety and efficacy of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in monotherapy and in combination therapy with antihyperglycemic agents in patients with type 2 diabetes mellitus - An interim analysis of post-marketing surveillance, RUBY-

Takashi Kadowaki, Masakazu Haneda, Hiroshi Ito, Kazuyo Sasaki, Manabu Ishii, Makoto Ueno, Sonoe Baba, Miyuki Matsukawa, Yumi Watanabe

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety and efficacy of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in monotherapy and in combination therapy with antihyperglycemic agents in patients with type 2 diabetes mellitus - An interim analysis of post-marketing surveillance, RUBY-'. Together they form a unique fingerprint.

Medicine & Life Sciences